ARTL - Artelo Biosciences Inc
1.17
0.030 2.564%
Share volume: 273,235
Last Updated: 03-09-2026
Pharmaceutical Products/Pharmaceutical Preparations:
3.20%
PREVIOUS CLOSE
CHG
CHG%
$1.14
0.03
0.03%
View ratios
| Fiscal Date | 12-31-2024 | 03-31-2025 | 06-30-2025 | 09-30-2025 | 12-31-2025 | |
|---|---|---|---|---|---|---|
| Fiscal Quarter | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
| Report Date | 03-03-2025 | 05-13-2025 | 08-13-2025 | 11-12-2025 | 02-24-2026 | |
| Cash flow financing | 57.000 K | 0.000 | 1.816 M | 3.444 M | 1.607 M | |
| Other financing cash flows | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Cash flow | -2.010 M | -1.597 M | 0.000 | -304.000 K | -1.116 M | |
| Net income | -3.778 M | -2.372 M | -3.221 M | -3.120 M | -4.166 M | |
| Depreciation | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Changes in inventories | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Changes in receivables | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Investing Cashflow | 500.000 K | 0.000 | 0.000 | -250.000 K | 188.000 K | |
| Net Borrowings | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Investing Activity Other | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Dividends Paid | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Exchange Rate Effect | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Capital Expenditures | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Cash Change | -14.115 M | -1.592 M | 1.320 M | -346.000 K | -1.120 M |